Bank of America Securities Reaffirms Their Hold Rating on Amphastar Pharmaceuticals (AMPH)
Amphastar Pharma Analyst Ratings
Piper Sandler Reiterates Overweight on Amphastar Pharma, Maintains $71 Price Target
Amphastar Pharmaceuticals (AMPH) Receives a Buy From Piper Sandler
Amphastar Pharma Analyst Ratings
Amphastar Pharmaceuticals Holds Steady Amidst New Approval and Competitive Market
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Erasca (ERAS)
Amphastar Pharmaceuticals (AMPH) Receives a Buy From Piper Sandler
Amphastar Pharma Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Phibro Animal Health (PAHC) and Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Ascendis Pharma (ASND) and AMN Healthcare Services (AMN)
Needham: Reiterates that Amphastar Pharma (AMPH.US) holds the rating.
Amphastar Pharma Analyst Ratings
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
Amphastar Pharma Analyst Ratings
Needham Remains a Hold on Amphastar Pharmaceuticals (AMPH)
Analysts Offer Insights on Healthcare Companies: Amphastar Pharmaceuticals (AMPH) and Schrodinger (SDGR)
Piper Sandler Remains a Buy on Amphastar Pharmaceuticals (AMPH)
Analysts' Top Healthcare Picks: Autolus Therapeutics (AUTL), Amphastar Pharmaceuticals (AMPH)